Regulation of hepatic lipase and serum lipoproteins by sex steroids.

[1]  S. Rössner,et al.  Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. , 2009, Acta medica Scandinavica.

[2]  Nikkilä Ea,et al.  Oral contraceptives and lipoprotein metabolism. , 1986 .

[3]  S. Eisenberg,et al.  Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases. , 1986, The Journal of biological chemistry.

[4]  T. Archer,et al.  Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells. , 1986, The Journal of biological chemistry.

[5]  H. J. Sips,et al.  Human hepatoma (Hep G2) cultures contain salt-resistant triglyceridase ("liver lipase"). , 1986, Life sciences.

[6]  E. Nikkilä,et al.  Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review. , 1986, Maturitas.

[7]  H. J. Sips,et al.  Monoclonal antibodies against salt-resistant rat liver lipase. Cross-reactivity with lipases from rat adrenals and ovaries. , 1986, Biochimica et biophysica acta.

[8]  U. Stenman,et al.  Variation of postheparin plasma hepatic lipase by menstrual cycle. , 1986, Metabolism: clinical and experimental.

[9]  P. Thompson,et al.  Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. , 1985, Medicine and science in sports and exercise.

[10]  M. Phillips,et al.  Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture. , 1985, Biochemistry.

[11]  E. Nikkilä,et al.  Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2. , 1985, Atherosclerosis.

[12]  T. Sane,et al.  Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen , 1985, FEBS letters.

[13]  A. Gotto,et al.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. , 1984, The Journal of clinical investigation.

[14]  H. Jansen,et al.  Regulation of liver lipase: II. Involvement of the α1-receptor☆ , 1984 .

[15]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[16]  H. Jansen,et al.  Regulation of liver lipase. I. Evidence for several regulatory sites, studied in corticotrophin-treated rats. , 1983, Biochimica et biophysica acta.

[17]  S. Yeaman,et al.  Salt-resistant (hepatic) lipase. Evidence for its presence in bovine liver and adrenal cortex. , 1983, Biochimica et biophysica acta.

[18]  H. Brewer,et al.  The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. , 1983, The Journal of clinical endocrinology and metabolism.

[19]  G. Rothblat,et al.  Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. , 1983, Journal of lipid research.

[20]  P. Groot,et al.  Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase. , 1983, Biochimica et biophysica acta.

[21]  S. Haffner,et al.  Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. , 1983, Metabolism: clinical and experimental.

[22]  B. Lewis,et al.  Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency , 1982, FEBS letters.

[23]  I. Goldberg,et al.  Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. , 1982, The Journal of clinical investigation.

[24]  J. Little,et al.  Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. , 1982, Atherosclerosis.

[25]  W. Hazzard,et al.  Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. , 1982, Metabolism: clinical and experimental.

[26]  G. Steiner,et al.  Roles of Lipoprotein Lipase and Hepatic Triglyceride Lipase in the Catabolism In Vivo of Triglyceride‐Rich Lipoproteins , 1982, Arteriosclerosis.

[27]  M. Taskinen,et al.  Human postheparin plasma hepatic lipase activity against triacylglycerol and phospholipid substrates. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[28]  E. Nikkilä,et al.  High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. , 1982, The Journal of clinical endocrinology and metabolism.

[29]  E. Nikkilä,et al.  Effects of oestradiol and levonorgestrel on lipoprotein lipids and postheparin plasma lipase activities in normolipoproteinaemic women. , 1982, Acta endocrinologica.

[30]  E. Nikkilä,et al.  Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity. , 1981, Atherosclerosis.

[31]  T. Pyörälä,et al.  Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. , 1981, Scandinavian journal of clinical and laboratory investigation.

[32]  E. Nikkilä,et al.  Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[33]  P. Groot,et al.  Selective degradation of the high density lipoprotein‐2 subfraction by heparin‐releasable liver lipase , 1981, FEBS letters.

[34]  H. Jansen,et al.  Heparin-releasable lipase activity of rat adrenals, ovaries and testes. , 1981, The Biochemical journal.

[35]  H. Itakura,et al.  Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. , 1981, Atherosclerosis.

[36]  K. Shirai,et al.  Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase. , 1981, Biochemical and biophysical research communications.

[37]  H. Greten,et al.  Function of hepatic triglyceride lipase in lipoprotein metabolism. , 1981, Journal of lipid research.

[38]  T. Olivecrona,et al.  The hepatic heparin releasable lipase binds to high density lipoproteins , 1980, FEBS letters.

[39]  E. Nikkilä,et al.  Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. , 1980, Atherosclerosis.

[40]  T. V. van Berkel,et al.  Properties of binding of lipases to non-parenchymal rat liver cells. , 1980, Biochimica et biophysica acta.

[41]  T. van Gent,et al.  Degradation of high density lipoprotein by heparin-releasable liver lipase. , 1980, Biochemical and biophysical research communications.

[42]  A. van Tol,et al.  On the metabolic function of heparin-releasable liver lipase. , 1980, Biochemical and biophysical research communications.

[43]  T. Musliner,et al.  Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma. , 1979, Biochimica et biophysica acta.

[44]  E. Nikkilä,et al.  Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo , 1979, FEBS letters.

[45]  P. Kinnunen,et al.  Localization of the heparin-releasable lipase in situ in the rat liver. , 1979, The Biochemical journal.

[46]  E. Vartiainen,et al.  TREATMENT OF POST‐MENOPAUSAL HYPERCHOLEROLAEMIA WITH ESTRADIOL , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.

[47]  S. Margolis,et al.  Release of phospholipase A and triglyceride lipase from rat liver. , 1978, The Journal of biological chemistry.

[48]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[49]  A. Goldberg,et al.  Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. , 1977, The Journal of clinical investigation.

[50]  J. Huttunen,et al.  Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma. , 1975, The New England journal of medicine.

[51]  C. Glueck,et al.  Effects of estrogenic compounds on triglyceride kinetics. , 1975, Metabolism: clinical and experimental.

[52]  Wynn,et al.  Mechanism of Hypertriglyceridaemia Associated with Contraceptive Steroids , 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[53]  W. Hazzard,et al.  Oral contraceptives and triglyceride transport: acquired heparin resistance as the mechanism for impaired post-heparin lipolytic activity. , 1972, The Journal of clinical endocrinology and metabolism.

[54]  E. Nikkilä,et al.  Plasma triglyceride turnover during use of oral contraceptives. , 1971, Metabolism: clinical and experimental.

[55]  H. Eder,et al.  Influence of gonadal hormones on protein-lipid relationships in human plasma. , 1955, The American journal of medicine.

[56]  D. P. Barr,et al.  The George E. Brown Memorial Lecture: Some Chemical Factors in the Pathogenesis of Atherosclerosis , 1953, Circulation.

[57]  G. Getz,et al.  Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. , 1985, The Journal of clinical endocrinology and metabolism.

[58]  F. Neumann.  The physiological action of progesterone and the pharmacological effects of progestogens--a short review. , 1978, Postgraduate medical journal.

[59]  R. Krauss,et al.  Selective Measurement of Lipoprotein Lipase and Hepatic Lipase in Post-Heparin Plasma , 1974 .